Sebastian Simon1,2, Heinrich Resch1,3, Friedrich Lomoschitz4, Bernhard J H Frank2, Roland Kocijan5,6,7. 1. II Medical Department, St. Vincent Hospital Vienna, Vienna, Austria. 2. Michael-Ogon Laboratory for Orthopaedic Research, Orthopaedic Hospital Vienna-Speising, Vienna, Austria. 3. Medical Faculty of Bone Diseases, Sigmund Freud University Vienna, Vienna, Austria. 4. Department of Diagnostic and Interventional Radiology, Hospital Hietzing, Vienna, Austria. 5. Medical Faculty of Bone Diseases, Sigmund Freud University Vienna, Vienna, Austria. roland.kocijan@osteologie.lbg.ac.at. 6. Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Center Vienna-Meidling, Vienna, Austria. roland.kocijan@osteologie.lbg.ac.at. 7. I Medical Department, Hanusch Hospital Vienna, Heinrich Collin-Str. 30, 1140, Vienna, Austria. roland.kocijan@osteologie.lbg.ac.at.
Abstract
CASE: A 73-year-old male patient presented with a 3-month history of back pain. In bone scintigraphy and the FDG PET-CT scan (fluorodeoxyglucose positron-emission computed tomography), highly suspect uptake levels were found in TH12-L1. Accordingly, an osteodestructive process was found on MRI (magnetic resonance imaging). Following a successfully performed biopsy of TH12, histologic analysis of the bone material revealed a chondrosarcoma (G1; T4N2M0). Complete resection of the tumor was successfully performed, since chondrosarcoma are resistant to radiation and chemotherapy. CONCLUSION: As chondrosarcoma is a rare bone neoplasm, it must be considered in the differential diagnosis of lower back pain to initiate adequate treatment.
CASE: A 73-year-old male patient presented with a 3-month history of back pain. In bone scintigraphy and the FDG PET-CT scan (fluorodeoxyglucose positron-emission computed tomography), highly suspect uptake levels were found in TH12-L1. Accordingly, an osteodestructive process was found on MRI (magnetic resonance imaging). Following a successfully performed biopsy of TH12, histologic analysis of the bone material revealed a chondrosarcoma (G1; T4N2M0). Complete resection of the tumor was successfully performed, since chondrosarcoma are resistant to radiation and chemotherapy. CONCLUSION: As chondrosarcoma is a rare bone neoplasm, it must be considered in the differential diagnosis of lower back pain to initiate adequate treatment.
Authors: Laura M Finucane; Aron Downie; Christopher Mercer; Susan M Greenhalgh; William G Boissonnault; Annelies L Pool-Goudzwaard; Jason M Beneciuk; Rachel L Leech; James Selfe Journal: J Orthop Sports Phys Ther Date: 2020-05-21 Impact factor: 4.751
Authors: Zach Pennington; Jeff Ehresman; Patricia D Pittman; A Karim Ahmed; Daniel Lubelski; Edward F McCarthy; C Rory Goodwin; Daniel M Sciubba Journal: Spine J Date: 2021-05-08 Impact factor: 4.166
Authors: Andrés Redondo; Silvia Bagué; Daniel Bernabeu; Eduardo Ortiz-Cruz; Claudia Valverde; Rosa Alvarez; Javier Martinez-Trufero; Jose A Lopez-Martin; Raquel Correa; Josefina Cruz; Antonio Lopez-Pousa; Aurelio Santos; Xavier García Del Muro; Javier Martin-Broto Journal: Cancer Chemother Pharmacol Date: 2017-10-16 Impact factor: 3.333
Authors: Julian Fromm; Alexander Klein; Andrea Baur-Melnyk; Thomas Knösel; Lars Lindner; Christof Birkenmaier; Falk Roeder; Volkmar Jansson; Hans Roland Dürr Journal: BMC Cancer Date: 2018-08-24 Impact factor: 4.430